Dr Maria Lucibello

Researcher

1990: Degree in Biological Science, University of Florence, Italy. 1991: Professional qualification as Biologist, University of Florence, Italy
1992-1994: Staff Scientific Researcher at the Department of Internal Medicine, Laboratory of Experimental Hemathology, University of Florence, Italy
1992: Visiting Researcher at Merck, laboratory of Cellular and Molecular Biology, West Point, PA (USA).
1993: Visiting Researcher at the Laboratory of Clinical Pathology, National Institute for Cancer Research, Genoa, Italy.
1995-1996: Research fellow at Rigshospitalet of Copenhagen, Department of Clinical Pharmacology, University of Copenhagen, Denmark.
1997-1998: Senior Scientific at the Department of Experimental Medicine and Biological Science, University of Rome Tor Vergata, Italy.
November 1999-09: Researcher at National Research Council, Institute of Neurobiology and Molecular Medicine, CNR, Italy. Host at the Department of Clinical Physiopathology, University of Florence, Italy.
2009 to March 2022: Permanent researcher position at National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome Italy. Group Leader of the Laboratory “Molecular mechanisms of cellular response to environmental stress.
From 1 April 2022, Researcher with permanent contract at the Institute for Biomedical Research and Innovation (I.R.I.B.) of Catanzaro.

Principal activities and responsibilities:
- 2013-2015: tutor for graduate and PhD student’s thesis from University of Rome “Tor Vergata”;
- 2016: Project Evaluation Reviewer for the Ministry of Scientific Research and Education (MIUR);
- 2017: Referee from the "Reprise" database of international experts of the Italian Ministry of University and Research to review a "Blue Sky Research" proposal;
- 2017: Reviewer for evaluation of Proposals Research grants JUNIOR University of Insubria, Italy;
- 2020: Reviewer for evaluation of project proposal No. 21-19189S Czech Science Foundation Editorial activities;
- Reviewer for the journals: Journal of Asthma and Allergy, Clinical Biochemistry, BMC Cancer, Polar Biology, Cellular Physiology and Biochemistry, Oncotarget, Cell Communication and Signaling, Cellular Physiology and Biochemistry, Cancer Science, Cancer Letters, Cancer Biomarkers, Cancer Medicine, Cancer MPDA, International Journal of Biological Sciences, Molecules, Pharmaceuticals, International Journal of Molecular Sciences.

Member of the following Scientific Societies:
- Italian Society of Cancerology (SIC);
- Italian Cancer Society and European Association for Cancer Research (EACR).

Editorial activities:
- Reviewer for the journals: Journal of Asthma and Allergy.
- Clinical Biochemistry.
- BMC Cancer.
- Polar Biology.
- Cellular Physiology and Biochemistry.
- Oncotarget.
- Cell Communication and Signaling.
- Cellular Physiology and Biochemistry.
- Cancer Science.
- Cancer Letters.
- Cancer Biomarkers.
- Cancer Medicine.
- Cancer MPDA.
- International Journal of Biological Sciences.
- Molecules.
- Pharmaceuticals.
- International Journal of Molecular Sciences.

Publications:16 original articles.

H-index:14

Total citations:1031

Average Citations per Year:35.96

Total IF:111, 359

Average impact factor:6,9

Research Arctivity:
- Molecular mechanisms of cellular responses to oxidative and metabolic stress in cancer cells;
- Anti-tumor effect and potential mechanism of Dihydroartemisinin;
- translational research projects based on a collaboration between basic and clinical researchers of the Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.< br>

Projects:

-Project of Strategic Interest Aging PNR-CNR 2012-2014 (B81J12001510001).
- FIRB Progetti Autonomi 2001 (RBAU01PXLN_001).
- Programma ITALIA-USA “FARMACOGENOMICA ONCOLOGICA” (N. 527/B-B5-17/05/2004).
- FIRB Negoziali- PNR 2001-2003 (RBNE01NWCH_006).
- Programma Biotecnologie" MURST-CNR, legge 95/95 (CU03.00098 PF/33).
- Progetto Finalizzato: Biotecnologie, 1998.
- Programma MURST-CNR 1998: Principal Investigator”Definizione biochimica dei processi apoptotici in corso di ipossia”. Progetto Ricerca Finalizzata 1998 (N. ICS 120.4/RF98.8.).
- Progetto Finalizzato: Biotecnologie, 1998.
- Programma MURST-CNR 1998.